This volume reviews the new potential treatments and research in the area of Alzheimer's disease. Special attention is given to international developments in all fields relevant to new drug development. Topics discussed include: progress in the international harmonization of drug development guidelines for dementia drugs; bioethics and law; development of rating instruments; behavioural treatments; and the activities of the Reagan Foundation. The text integrates basic and clinical research findings, and provides evaluation of new approaches to therapy by world leaders in the field. The…mehr
This volume reviews the new potential treatments and research in the area of Alzheimer's disease. Special attention is given to international developments in all fields relevant to new drug development. Topics discussed include: progress in the international harmonization of drug development guidelines for dementia drugs; bioethics and law; development of rating instruments; behavioural treatments; and the activities of the Reagan Foundation. The text integrates basic and clinical research findings, and provides evaluation of new approaches to therapy by world leaders in the field. The potential benefit for Alzheimer patients and families resulting from these research programmes, from molecular biology to clinical pharmacology, is reviewed and evaluated.Hinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.
Die Herstellerinformationen sind derzeit nicht verfügbar.
Autorenporträt
Dr. Robert Becker ist Inhaber der Unternehmensberatung BBH-Marketing-Management in Bensheim, die sich darauf spezialisiert hat, Unternehmen bei der markt- und kundenorientierten Neuausrichtung zu begleiten. Sein Buch "Besser miteinander umgehen" ist 1994 erschienen.
Inhaltsangabe
I. Pathological Basis of Therapy in Alzheimer's Disease.- Criteria for the Diagnosis of Alzheimer's Disease.- Neuropathology Of Alzheimer's Disease.- Processing of Amyloid, Cytoskeletal Damage and Apolipoproteins.- Cell Death: Excitotoxins, Apoptosis And Hypometabolism.- Neurotrophins, Growth Factors and Neuroprotectors.- Animal Models.- II. The Cholinergic System in Brain.- Treatment of Alzheimer Disease.- Cholinesterase Inhibitors in Alzheimer Disease Treatment.- III. Nicotinic and Muscarinic Cholinergic Agonists.- Nicotinic Agonists.- Muscarinic Agonists and Antagonists.- The Potential of Antioxidant Therapy.- The Potential for Anti-Inflammatory Therapy.- IV. Development of New Therapies in Alzheimer Disease.- Design of Clinical Trials.- Advances in Assessment.- SPECT and PET.- Potential Markers of Disease Progression and Drug Efficacy in Alzheimer's Disease.- Treatment of Behavioral and Psychosocial Disturbances.- V. Social Issue in Alzheimer Disease.- Legal and Ethical Issues.- Socio-Economic As pects of Alzheimer Disease Treatment.- International Harmonization of Drug Guidelines.- Research Priorities in Alzheimer Disease Treatment - An International Perspective.- Author Index.
I. Pathological Basis of Therapy in Alzheimer's Disease.- Criteria for the Diagnosis of Alzheimer's Disease.- Neuropathology Of Alzheimer's Disease.- Processing of Amyloid, Cytoskeletal Damage and Apolipoproteins.- Cell Death: Excitotoxins, Apoptosis And Hypometabolism.- Neurotrophins, Growth Factors and Neuroprotectors.- Animal Models.- II. The Cholinergic System in Brain.- Treatment of Alzheimer Disease.- Cholinesterase Inhibitors in Alzheimer Disease Treatment.- III. Nicotinic and Muscarinic Cholinergic Agonists.- Nicotinic Agonists.- Muscarinic Agonists and Antagonists.- The Potential of Antioxidant Therapy.- The Potential for Anti-Inflammatory Therapy.- IV. Development of New Therapies in Alzheimer Disease.- Design of Clinical Trials.- Advances in Assessment.- SPECT and PET.- Potential Markers of Disease Progression and Drug Efficacy in Alzheimer's Disease.- Treatment of Behavioral and Psychosocial Disturbances.- V. Social Issue in Alzheimer Disease.- Legal and Ethical Issues.- Socio-Economic As pects of Alzheimer Disease Treatment.- International Harmonization of Drug Guidelines.- Research Priorities in Alzheimer Disease Treatment - An International Perspective.- Author Index.
Es gelten unsere Allgemeinen Geschäftsbedingungen: www.buecher.de/agb
Impressum
www.buecher.de ist ein Internetauftritt der buecher.de internetstores GmbH
Geschäftsführung: Monica Sawhney | Roland Kölbl | Günter Hilger
Sitz der Gesellschaft: Batheyer Straße 115 - 117, 58099 Hagen
Postanschrift: Bürgermeister-Wegele-Str. 12, 86167 Augsburg
Amtsgericht Hagen HRB 13257
Steuernummer: 321/5800/1497
USt-IdNr: DE450055826